2025 @ Avira Digital Enterprise-Grade AI. Vertical Impact. Scaled Growth
This Year, Avira Life Sciences Strengthened its role as a trusted technology, engineering, and consulting partner, helping global pharma and organizations navigate complexity and drive measurable outcomes at scale.
What defined our AI Growth in 2025
Enterprise-grade AI deployed at scale.
Domain-centric vertical and horizontal AI agents deployed in client environments.
Connected and compliant data foundations.
Cutting-edge offering across the medical and commercial ecosystem.
Medical Affairs Transformation
We focused on digitizing the end-to-end Medical Affairs value chain with AI-first enterprise-ready platforms. We built pre-configured AI agents enabling automation anf turning insights to action.
Impact Through Evidence 360
100+
IEPs Digitized
10+
Therapeutic Areas
5
Worked with Top Pharma and Medtech Companies
Recognition & Trust
01
02
03
04
Events 2025
Maps
Fierce Pharma
Medical Affairs Nexus
